AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 132 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,000 | -98.8% | 6,210 | -96.0% | 0.00% | – |
Q3 2021 | $259,000 | +1.2% | 153,626 | 0.0% | 0.00% | – |
Q2 2021 | $256,000 | -20.7% | 153,626 | -19.9% | 0.00% | -100.0% |
Q1 2021 | $323,000 | +368.1% | 191,686 | +341.0% | 0.00% | – |
Q4 2020 | $69,000 | – | 43,470 | +14390.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 300 | -97.6% | 0.00% | -100.0% |
Q1 2018 | $41,000 | – | 12,326 | +8285.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 147 | -95.7% | 0.00% | – |
Q3 2017 | $2,000 | +100.0% | 3,400 | +6.2% | 0.00% | – |
Q2 2017 | $1,000 | -75.0% | 3,200 | -41.1% | 0.00% | – |
Q1 2017 | $4,000 | -83.3% | 5,434 | -80.0% | 0.00% | -100.0% |
Q4 2016 | $24,000 | +500.0% | 27,216 | +325.3% | 0.00% | – |
Q3 2016 | $4,000 | -86.2% | 6,399 | -72.0% | 0.00% | -100.0% |
Q2 2016 | $29,000 | +38.1% | 22,853 | +140.7% | 0.00% | 0.0% |
Q1 2016 | $21,000 | -38.2% | 9,494 | -4.0% | 0.00% | -33.3% |
Q4 2015 | $34,000 | -12.8% | 9,887 | -27.2% | 0.00% | 0.0% |
Q3 2015 | $39,000 | -18.8% | 13,580 | -34.0% | 0.00% | -25.0% |
Q2 2015 | $48,000 | +9.1% | 20,571 | +246.7% | 0.00% | -20.0% |
Q1 2015 | $44,000 | – | 5,934 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
NTB Financial Corp | 146,100 | $83,000 | 0.06% |
Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |